|
Octapharma AG is the largest privately owned human protein products manufacturer in the world. Founded in 1983 by Wolfgang Marguerre, Octapharma employs more than 5,500 people globally. Octapharma is owned by Wolfgang Marguerre and his three children, two of whom, Frederic Marguerre and Tobias Marguerre, sit on the management board. Octapharma's core business is the development and production of human proteins from human blood plasma and human cell-lines. It is headquartered in Lachen, Switzerland. == Products == Patients in over 100 countries are treated with products in the following therapeutic areas: * Haematology: high-purity coagulation factor concentrates for patients with bleeding disorders Haemophilia A, B and von Willebrand Disease * Immunotherapy : immunomodulation or immunoglobulin replacement therapy for the treatment of immune-mediated diseases and deficiencies (immune disorders including autoimmune diseases and antibody deficiency) by inducing, enhancing, or suppressing an immune response. * Critical Care: human plasma and protein products for treating critically ill or injured patients in intensive care and emergency medicine settings. 〔Octapharma Website http://www.octapharma.com/en/patients/diseases-therapies.html〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Octapharma」の詳細全文を読む スポンサード リンク
|